OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 39 filers reported holding OCUPHIRE PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43,651 | -17.9% | 13,030 | +6.4% | 0.01% | -16.7% |
Q2 2023 | $53,165 | +17.0% | 12,250 | +1.1% | 0.01% | 0.0% |
Q1 2023 | $45,450 | +6.2% | 12,120 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $42,784 | +78.3% | 12,120 | 0.0% | 0.01% | +100.0% |
Q3 2022 | $24,000 | +4.3% | 12,120 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $23,000 | -41.0% | 12,120 | 0.0% | 0.00% | -40.0% |
Q1 2022 | $39,000 | -13.3% | 12,120 | 0.0% | 0.01% | -16.7% |
Q4 2021 | $45,000 | -27.4% | 12,120 | 0.0% | 0.01% | -33.3% |
Q3 2021 | $62,000 | -3.1% | 12,120 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $64,000 | -8.6% | 12,120 | 0.0% | 0.01% | -18.2% |
Q1 2021 | $70,000 | – | 12,120 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |